|
|
ix | |
Woodhead Publishing Series in Biomaterials |
|
xi | |
|
Part One Introduction to biomaterials and medical device-related infections |
|
|
1 | (100) |
|
1 Introduction to biomaterials and medical device-associated infections |
|
|
3 | (16) |
|
|
1.1 History of biomaterials |
|
|
3 | (2) |
|
1.2 Overview of current medical devices and applications |
|
|
5 | (2) |
|
1.3 Overview of problems associated with medical devices |
|
|
7 | (6) |
|
1.4 Introduction to the structure of this book |
|
|
13 | (6) |
|
|
14 | (5) |
|
2 Biofilms and implant-associated infections |
|
|
19 | (28) |
|
|
|
|
|
19 | (1) |
|
2.2 Microbial profile of implant-associated infections |
|
|
19 | (4) |
|
2.3 Relevance of biofilms in implant-associated infections |
|
|
23 | (1) |
|
2.4 Structure and composition of biofilms |
|
|
24 | (2) |
|
2.5 Pathogenesis of biofilm infection |
|
|
26 | (10) |
|
|
36 | (1) |
|
2.7 Further information and advice |
|
|
36 | (11) |
|
|
37 | (10) |
|
3 In vivo infection studies |
|
|
47 | (24) |
|
|
|
|
|
47 | (1) |
|
3.2 Legitimacy of animal studies |
|
|
48 | (1) |
|
3.3 Choosing the right animal model to study device-associated infections |
|
|
49 | (11) |
|
3.4 Pros and cons of in vivo infection studies |
|
|
60 | (2) |
|
3.5 Correlation of outcome between animal and clinical studies |
|
|
62 | (1) |
|
3.6 Conclusion and future trends |
|
|
63 | (1) |
|
3.7 Sources of further information and advice |
|
|
63 | (8) |
|
|
64 | (1) |
|
|
64 | (7) |
|
4 Diagnosis of biofilm-associated infections in medical devices |
|
|
71 | (12) |
|
|
|
|
71 | (1) |
|
4.2 Importance of detection of biofilm |
|
|
72 | (1) |
|
4.3 Sites of biofilm formation |
|
|
73 | (1) |
|
4.4 Collection of samples for biofilm detection |
|
|
73 | (1) |
|
4.5 Examples of methods for the detection of biofilms associated with infections |
|
|
74 | (4) |
|
|
78 | (1) |
|
|
79 | (4) |
|
|
79 | (1) |
|
|
79 | (4) |
|
5 Diagnosis and treatment of implant-associated infections |
|
|
83 | (18) |
|
|
|
|
|
|
|
|
83 | (1) |
|
5.2 Risk factors and prevention |
|
|
84 | (3) |
|
|
87 | (1) |
|
|
88 | (8) |
|
|
96 | (5) |
|
|
96 | (5) |
|
Part Two Technologies and materials for controlling biofilms |
|
|
101 | (154) |
|
6 Surface modification of biomaterials for biofilm control |
|
|
103 | (30) |
|
|
|
|
103 | (1) |
|
6.2 Principles of bacterial cell--biomaterial surface interactions |
|
|
103 | (2) |
|
6.3 Substrate specific biological response |
|
|
105 | (1) |
|
6.4 Looking at nature for inspiration |
|
|
106 | (1) |
|
6.5 Modifications to prevent initial stages of bacterial adhesion |
|
|
107 | (2) |
|
6.6 Methods to prevent irreversible attachment of microorganisms |
|
|
109 | (1) |
|
6.7 Mitigation of biofilm formation by attached organisms |
|
|
110 | (13) |
|
|
123 | (10) |
|
|
124 | (9) |
|
7 Surface nanoengineering for combating biomaterials infections |
|
|
133 | (30) |
|
|
|
|
|
133 | (1) |
|
7.2 Modification of surface nano topography to inhibit bacterial adhesion |
|
|
134 | (2) |
|
7.3 Surface functionalization with eluting antibacterial agent |
|
|
136 | (4) |
|
7.4 Surface functionalization with anti-adhesive polymers |
|
|
140 | (6) |
|
7.5 Immobilization of bactericidal moieties on surfaces |
|
|
146 | (6) |
|
7.6 Conclusion and future trends |
|
|
152 | (1) |
|
7.7 Sources of further information and advice |
|
|
153 | (10) |
|
|
153 | (10) |
|
8 Bioactive biomaterials for controlling biofilms |
|
|
163 | (22) |
|
|
|
|
163 | (2) |
|
8.2 Definition of medical device |
|
|
165 | (1) |
|
|
165 | (2) |
|
8.4 Biomaterial applications in medical devices |
|
|
167 | (4) |
|
8.5 Post-implantation device-associated infections |
|
|
171 | (2) |
|
8.6 Development of conventional antimicrobial biomaterials |
|
|
173 | (7) |
|
|
180 | (5) |
|
|
180 | (5) |
|
9 Antibiotics and cements for the prevention of biofilm-associated infections |
|
|
185 | (14) |
|
|
|
|
|
|
|
|
185 | (1) |
|
9.2 Biomaterials, infections and orthopedics |
|
|
185 | (1) |
|
9.3 History of antibiotic-loaded bone cement (ALBC) |
|
|
186 | (1) |
|
|
186 | (1) |
|
9.5 Method of mixing the ALBC |
|
|
187 | (1) |
|
9.6 The choice of antibiotic, its dosage and associations of different drugs |
|
|
188 | (3) |
|
9.7 The antibiotic release |
|
|
191 | (1) |
|
9.8 Mechanical properties of ALBC |
|
|
192 | (1) |
|
|
193 | (1) |
|
|
193 | (6) |
|
|
194 | (5) |
|
10 Antibacterial composite restorative materials for dental applications |
|
|
199 | (24) |
|
|
|
|
199 | (1) |
|
10.2 Current direct aesthetic restorative materials |
|
|
200 | (1) |
|
10.3 Antibacterial properties of aesthetic restorative materials |
|
|
201 | (5) |
|
10.4 Re-mineralizing dental composites |
|
|
206 | (2) |
|
10.5 Antibacterial, re-mineralizing and proteinases inhibiting materials |
|
|
208 | (5) |
|
10.6 Conclusion and future trends |
|
|
213 | (10) |
|
|
213 | (10) |
|
11 Infection resistant biomaterials |
|
|
223 | (32) |
|
|
|
|
|
223 | (1) |
|
|
224 | (1) |
|
11.3 Drug-releasing antimicrobial systems |
|
|
225 | (6) |
|
11.4 Antimicrobial cationic systems |
|
|
231 | (3) |
|
11.5 Antifouling surfaces |
|
|
234 | (4) |
|
11.6 Naturally occurring antifouling surfaces |
|
|
238 | (2) |
|
11.7 Silver ions and silver-containing surfaces |
|
|
240 | (2) |
|
|
242 | (13) |
|
|
242 | (12) |
|
|
254 | (1) |
Index |
|
255 | |